Albion Financial Group’s Biogen BIIB Stock Holding History

Albion Financial Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.3K	Hold	6	–	–	﹤0.01%	583
2026 Q1	$1.1K	Hold	6	–	–	﹤0.01%	634
2025 Q4	$1.06K	Hold	6	–	–	﹤0.01%	591
2025 Q3	$841	Hold	6	–	–	﹤0.01%	603
2025 Q2	$754	Hold	6	–	–	﹤0.01%	537
2025 Q1	$822	Hold	6	–	–	﹤0.01%	549
2024 Q4	$918	Buy	+6	New	+$1.01K	﹤0.01%	618
2024 Q2	–	Sell	-75	Closed	-$16.2K	–	513
2024 Q1	$16.2K	Hold	75	–	–	﹤0.01%	291
2023 Q4	$19.4K	Hold	75	–	–	﹤0.01%	274
2023 Q3	$19.3K	Hold	75	–	–	﹤0.01%	263
2023 Q2	$21.4K	Hold	75	–	–	﹤0.01%	266
2023 Q1	$20.9K	Hold	75	–	–	﹤0.01%	263
2022 Q4	$20.8K	Hold	75	–	–	﹤0.01%	258
2022 Q3	$20K	Hold	75	–	–	﹤0.01%	260
2022 Q2	$15K	Hold	75	–	–	﹤0.01%	290
2022 Q1	$16K	Hold	75	–	–	﹤0.01%	329
2021 Q4	$18K	Hold	75	–	–	﹤0.01%	362
2021 Q3	$21K	Hold	75	–	–	﹤0.01%	319
2021 Q2	$26K	Buy	+75	New	+$22.7K	﹤0.01%	308
2020 Q4	$18K	Buy	+75	New	+$19.3K	﹤0.01%	316

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Albion Financial Group's BIIB Position: Q2 2026 in Review

Albion Financial Group held its Biogen (BIIB) position steady in Q2 2026 at 6 shares worth $1.3K. The position accounts for ﹤0.01% of the portfolio, ranked #583.

Albion Financial Group first reported a position in BIIB in Q4 2020 and has held it in 20 quarters since. The position peaked at $26K in Q2 2021. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Albion Financial Group held 6 shares of Biogen worth $1.3K as of Q2 2026.
Albion Financial Group left its Biogen share count unchanged in Q2 2026.
Biogen made up ﹤0.01% of Albion Financial Group's portfolio in Q2 2026, its #583 holding.
Albion Financial Group first reported a position in Biogen in Q4 2020 and has held it in 20 quarters since.
Albion Financial Group's Biogen position peaked at $26K in Q2 2021.
1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Albion Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.